FIELD: medicine, pharmacy. SUBSTANCE: composition for intranasal administration has nicotine solution or its pharmaceutically acceptable salt in pharmaceutical solvent and an agent making viscosity at the range 1-99 centipoises. Composition has nicotine concentration at the range 10-40 mg/ml. Method of decrease of tobacco smoking dependence in human involves intranasal administration of effective dose of composition. The use of new nicotine-containing composition ensures to avoid harmful effects of carcinogens and carbon monooxide on smokers and other men. Nicotine-containing composition does not effect on productive work of smoker. EFFECT: enhanced effectiveness of composition. 22 cl, 1 dwg, 1 ex
